Browse > Article
http://dx.doi.org/10.5392/JKCA.2021.21.02.248

The Effect of Blood Nutrient Index on Depression  

Noh, Hyun Sun (동방문화대학원대학교 뷰티예술학과)
Kim, Moon Ju (동방문화대학원대학교 뷰티예술학과)
Publication Information
The Journal of the Korea Contents Association / v.21, no.2, 2021 , pp. 248-261 More about this Journal
Abstract
The purpose of this study is that the blood nutrient indicator in adult women, is the depressive indicator. This study recruited 77 pre-menopausal women, and excluding missing values, 53 (mean age 44.2±6.5 years) blood indexes were statistically confirmed and then analyzed the effect of indexes on the Beck Depression Inventory. The Beck's Depression Inventory(BDI)'s average of the study subjects was 7.6±7.2, and most of the depression symptoms were within the normal range. Only two women were very serious and other two women were serious state. As a result of this study, 21 questions of BDI was classified into 5 sub-factors. Of these, 2 factors were considered physical depression, 1 factor was mood depression, 1 factor was cognitive depression, and 1 factor undecided. As a result of the correlation analysis, triglyceride, LDL(low density lipoprotein) cholesterol and potassium showed statistically significant positive relationship with depressive factors. On the other hand, HDL(high density lipoprotein) cholesterol, sodium and chloride ions showed negative relationship with depressive factors. When multiple regression analysis was performed. Considering the depression factors was dependent variable, and triglyceride, cholesterol, blood sugar, and ketone bodies was considered as independent variables. HDL(high density lipoprotein) cholesterol had a statistically significant negative effect on the depression factor 3. Considering the depression factors was dependent variable, and minerals were considered as independent variables. Potassium had a positive effect, and chloride ions had a negative effect on the depressive factor 3. This study was limited to 77 pre-menopausal women. In the future, post-menopausal women, men, and clinical neurological disorders group will be possible.
Keywords
Chloride; Depression; HDL Cholesterol Potassium; Sodium;
Citations & Related Records
연도 인용수 순위
  • Reference
1 S. K. W. Avram, H. J. Lee, J. Fastman, A. Cymerblit-Sabba, M. Vincent, and N. I. Cilz, "NMDA receptor in vasopressin 1b neurons is not required for short-term social memory, object memory or aggression," Frontiers in Behavioral Neuroscience, Vol.13, pp.1-20, 2019.   DOI
2 J. M. Woo, W. Kim, T. Y. Hwang, K. D. Frick, B. H. Chio, Y. J. Seo, and J. S. Lee, "Impact of depression on work productivity and its improvement after outpatient treatment with antidepressants," Value in Health, Vol.14, No.4, pp.475-482, 2011.   DOI
3 C. Li, F. Meng, J. C. Garza, J. Liu, Y. Lei, S. A. kirov, and X. Y. Lu, "Modulation of depression-related behaviors by adiponectin AdipoR1 receptors in 5-HT neurons," Molecular Psychiatry, pp.1-16, 2020.
4 L. A. Stone, E. S. Harmatz, and K. A. Goosens, "Ghrelin as a Stress Hormone: Implications for Psychiatric Illness," Biological Psychiatry, Vol.88, No.7, pp.531-540, 2020.   DOI
5 I. Bjorkhem and S. Meaney, "Brain cholesterol: long secret life behind a barrier," Arteriosclerosis, thrombosis, and vascular biology, Vol.24, No.5, pp.806-815, 2004.   DOI
6 C. Goritz, D. H. Mauch, and F. W. Pfrieger, "Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron," Molecular and Cellular Neuroscience, Vol.29, No.2, pp.190-201, 2005.   DOI
7 K. H. Pfenninger, "Plasma membrane expansion: a neuron's Herculean task," Nature Reviews Neuroscience, Vol.10, No.4, pp.251-261, 2009.   DOI
8 G. W. Blair-West, C. H. Cantor, G. W. Mellsop, and M. L. Eyeson-Annan, "Lifetime suicide risk in major depression: sex and age determinants," Journal of affective disorders, Vol.55, No.2-3, pp.171-178, 1999.   DOI
9 P. Alboni, E. Favaron, N. Paparella, M. Sciammarella, and M. Pedaci, "Is there an association between depression and cardiovascular mortality or sudden death?," Journal of Cardiovascular Medicine, Vol.9, No.4, pp.356-362, 2008.   DOI
10 T. Partonen, J. Haukka, J. Virtamo, P. Taylor, and J. Lonnqvist, "Association of low serum total cholesterol with major depression and suicide," The British Journal of Psychiatry, Vol.175, No.3, pp.259-262, 1999.   DOI
11 G. Saher, B. Brugger, C. Lappe-Siefke, W. Mobius, R-r. Tozawa, M. C. Wehr, and K. A. Nave, "High cholesterol level is essential for myelin membrane growth," Nature neuroscience, Vol.8, No.4, pp.468-475, 2005.   DOI
12 E. S. Lee,1, Y. H. Kim, S. H. Beck, S. Y. Lee, and S. W. Oh, "Depressive mood and abdominal fat distribution in overweight premenopausal women," Obesity Research, Vol.13, No.2, pp.320-325, 2005.   DOI
13 A. Gupta, S. Petker, A. Jadhav, and V. Dubey, "Study of lipid derangement in pyschiatric disorder," Ind Med Gazt, Vol.147. No.7, pp.253-256, 2013.
14 I. H. Franken, I. Nijs, and L. Pepplinkhuizen, "Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli." Psychopharmacology (Berl), Vol.195, No.4, pp.537-546, 2008.   DOI
15 T. Terao, N. lwata, K. Kanazawa, T. Takano, N. Takahashi, T. Hayashi, and Y. Sugawara, "Low serum cholesterol levels and depressive state in human dock visitors," Acta Psychiatrica Scandinavica, Vol.101, No.3, pp.231-234, 2000.   DOI
16 A. Agorastos, A. Sommer, A. Heinig, K. Wiedemann, and C. Demiralay, "Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study," Frontiers in Psychiatry, Vol.11, p.453, 2020.   DOI
17 M. F. Lokhandwala, "Role of kidney dopamine in sodium excretion," Peripheral dopamine pathophysiology, pp.79-86, 2019.
18 A. Alcaro, R. Huber, and J. Panksepp, "Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective," Brain research reviews, Vol.56, No.2, pp.283-321, 2007.   DOI
19 A. Zauner, W. P. Daugherty, M. R. Bullock, and D. S. Warner, "Brain oxygenation and energy metabolism: part I-biological function and pathophysiology," Neurosurgery, Vol.51, No.2, pp.289-301, discussion 302, 2002.   DOI
20 F. T. Endomba, A. T. Tankeu, J.R. Nkeck, and J. N. Tochie, "Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?," Lipids in Health and Disease, Vol.19, No.1, pp.1-12, 2020.   DOI
21 A. T. Beck, R. A. Steer, and G. K. Brown, Beck depression inventory (BDI-II), Pearson, 1996.
22 S. Vanheule, M. Desmet, H. Grenvynck, Y. Rosseel, and J. Fontaine, "The Factor Structure of the Beck Depression Inventory-II An Evaluation," Assessment, Vol.15, pp.177-187, 2008.   DOI
23 M. Brown, C. Kaplan, and L. Jason, "Factor analysis of the Beck Depression Inventory-II with patients with chronic fatigue syndrome," Journal of health psychology, Vol.17, pp.799-808, 2011.   DOI
24 F. J. Gennari, "Disorders of potassium homeostasis: hypokalemia and hyperkalemia," Critical care clinics, Vol.18, No.2, pp.273-288, 2002.   DOI
25 J. Volpi-Abadie, A. M. Kaye, and A. D. Kaye, "Serotonin syndrome," The Ochsner journal, Vol.13, No.4, pp.533-540, 2013.
26 P. A. Alphonse and P. J. Jones, "Revisiting human cholesterol synthesis and absorption: the reciprocity paradigm and its key regulators," Lipids, Vol.51, No.5, pp.519-536, 2016.   DOI
27 S. Takamori, M. Holt, K. Stenius, E. A. Lemke, M. Gronborg, D. Riedel, and P. Ringler, "Molecular anatomy of a trafficking organelle," Cell, Vol.127, No.4, pp.831-846, 2006.   DOI
28 J. M. Dietschy and S. D. Turley, "Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal," Journal of lipid research, Vol.45, No.8, pp.1375-1397, 2004.   DOI
29 J. Zhang and Q. Liu, "Cholesterol metabolism and homeostasis in the brain," Protein & cell, Vol.6, No.4, pp.254-264, 2015.   DOI
30 A. A. Ariyo, M. Haan, C. M. tangen, J. C. Rutledge, M. Cushman, A. Dobs, and C. D. Furberg, "Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans," Circulation, Vol.102, No.15, pp.1773-1779, 2000.   DOI
31 J. Rabe-Jablonska and I. Poprawska, "Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission," Med Sci Monit, Vol.6, No.3, pp.539-547, 2000.
32 S. Major, G. C. Petzold, C. Reiffurth, O. Windmuller, M. Foddis, U. Lindauer, and J. P. Dreier, "A role of the sodium pump in spreading ischemia in rate," Journal of Cerebral Blood Flow & Metabolism, Vol.37, No.5, pp.1687-1705, 2017.   DOI
33 Y. Ben-Ari, "NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders," Trends Neurosci, Vol.40, No.9, pp.536-554, 2017.   DOI
34 E. Delpire and K. J. Staley, "Novel determinants of the neuronal Cl(-) concentration," The Journal of physiology, Vol.592, No.19, pp.4099-4114, 2014.   DOI
35 B. W. Penninx, A. T. Beekman, A. Honig, D. J. Deeg, R. A. Schoevers, J. T. van Eijk, and W. Van Tilburg, "Depression and cardiac mortality: results from a community-based longitudinal study," Archives of general psychiatry, Vol.58, No.3, pp.221-227, 2001.   DOI
36 M. Horsten, S. P. Wamala, A. Vingerhoets, and K. Orth-Gomer, "Depressive symptoms, social support, and lipid profile in healthy middle-aged women," Psychosomatic medicine, Vol.59, No.5, pp.521-528, 1997.   DOI
37 S. O. Olusi and A. A. Fido, "Serum lipid concentrations in patients with major depressive disorder," Biological Psychiatry, Vol.40, No.11, pp.1128-1131, 1996.   DOI
38 E. J. Martens, P. W. Hoen, M. Mittelheauser, P. de Jonge, and J. Denollet, "Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis." Psychol Med, Vol.40, No.5, pp.807-814, 2010.   DOI
39 A. T. Beck, C. H. Ward, M. Mendelsom, J. Mock, and J. Erbaugh, "An inventory for measuring depression," Archives of general psychiatry, Vol.4, No.6, pp.561-571, 1961.   DOI
40 W. Jiang, J. Alexander, E. Christopher, M. Kuchibhatla, L. H. Gaulden, M. S. Cuffe, and R. R. Krishnan, "Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure," Archives of internal medicine, Vol.161, No.15, pp.1849-1856, 2001.   DOI
41 J. I. Travella, A. W. Forrester, S. K. Schultz, and R. G. Robinson, "Depression following myocardial infarction: a one year longitudinal study," The International Journal of Psychiatry in Medicine, Vol.24, No.4, pp.357-369, 1994.   DOI
42 A. Trpkovic, I. Resanovic, J. Stanimirovic, D. Radak, S. A. mousa, D. Cenic-Milosevic, and E. R. lsenovic, "Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases," Critical reviews in clinical laboratory sciences, Vol.52, No.2, pp.70-85, 2015.   DOI
43 P. Barter, "The role of HDL-cholesterol in preventing atherosclerotic disease," European heart journal Supplements, Vol.7, suppl.F, pp.F4-F8, 2005.   DOI
44 J. M. Zich, C. C. Attkisson, and T. K. Greenfield, "Screening for depression in primary care clinics: the CES-D and the BDI," The International Journal of Psychiatry in Medicine, Vol.20, No.3, pp.259-277, 1990.   DOI
45 S. Mora, M. Szklo, J. D. Otvos, P. Greenland, B. M. Psaty, D. C. Goff Jr, and A. R. Hsarrett, "LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)," Atherosclerosis, Vol.192, No.1, pp.211-217, 2007.   DOI
46 M. Daujat-Chavanieu and M. Kot, "Albumin is a secret factor involved in multidirectional interactions among the serotoninergic, immune and endocrine systems that supervises the mechanism of CYP1A and CYP3A regulation in the liver," Pharmacology & Therapeutics, Vol.215, p.107616, 2020.   DOI
47 R. Colle, P. Masson, C. Verstuyft, B. Feve, E. Werner, C. Boursier-Neyret, and B. Falissard, "Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study," Psychiatry and Clinical Neurosciences, Vol.74, No.2, pp.112-117, 2020.   DOI
48 S. Mrug, C. Orihuela, M. Mrug, and P. W. Sanders, "Sodium and potassium excretion predict increased depression in urban adolescents," Physiological reports, Vol.7, No.16, pp.e14213-e14213, 2019.
49 M. Muller, "Effects of chloride transport inhibition and chloride substitution on neuron function and on hypoxic spreading-depression-like depolarization in rat hippocampal slices," Neuroscience, Vol.97, No.1, pp.33-45, 2000.   DOI
50 C. Nasca, J. Dobbin, B. Bigio, K. Watson, P. de Angelis, M. Kautz, and F. S. Lee, "Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance," Molecular Psychiatry, pp.1-10, 2020.
51 S. Moussavi, S. Chatterji, E. Verdes, A. tandon, V. Patel, and B. Ustun, "Depression, chronic diseases, and decrements in health: results from the World Health Surveys," The Lancet, Vol.370, No.9590, pp.851-858, 2007.   DOI
52 L. Gossec, J. Walsh, K. Michaud, E. holdsworth, S. Peterson, S. Meakin, and A. Ogdie, AB0821 ANXIETY AND DEPRESSION IN PSORIATIC ARTHRITIS (PsA)-PREVALENCE AND IMPACT ON PATIENT REPORTED OUTCOMES: REAL-WORLD SURVEY IN THE US AND EUROPE, BMJ Publishing Group Ltd., 2020.
53 O. Altindag, A. Altindag, M.Asoglu, M. Gunes, N. Soran, and Z. Deveci, "Relation of cortisol levels and bone mineral density among premenopausal women with major depression," International Journal of Clinical Practice, Vol.61, No.3, pp.416-420, 2007.   DOI
54 I. Chamma, Q. Chevy, J. C. Poncer, and S. Levi, "Role of the neuronal K-Cl co-transporter KCC2 in inhibitory and excitatory neurotransmission," Frontiers in cellular neuroscience, Vol.6, p.5, 2012.   DOI
55 J. T. Schulte, C. J. Wierenga, and H. Bruining, "Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions," Neurosci Biobehav Rev, Vol.90, pp.260-271, 2018.   DOI
56 F. Ali and C. B. Nemeroff, Neuroendocrine Alterations in Major Depressive Disorder, in Major Depressive Disorder, Elsevier, pp.63-74, 2020.
57 K. Nishimura,Yoshino, K. Sanada, H. Beppu, Y. Akiyama, H. Nishimura, and M. Yoshimura, "Effect of oestrogen-dependent vasopressin on HPA axis in the median eminence of female rats," Scientific reports, Vol.9, No.1, pp.1-9, 2019.   DOI
58 A. Agorastos, A. Sommer, A. Heinig, K. Wiedemann, and C. Demirala, "Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study," Frontiers in Psychiatry, Vol.11, p.453, 2020.   DOI
59 S. J. Torres and C. A. Nowson, "A moderate-sodium DASH-type diet improves mood in postmenopausal women," Nutrition, Vol.28, No.9, pp.896-900, 2012.   DOI
60 M. Szkup, A. Jurczak, A. Brodowska, L. Niocen, D. Chlubek, and E. Grochans, "Analysis of relations between the level of Mg, Zn, Ca, Cu, and Fe and depressiveness in postmenopausal women," Biological trace element research, Vol.176, No.1, pp.56-63, 2017.   DOI
61 D. Bennabi, B. Aouizerate, W. El-Hage, O. Doumy, F. Moliere, P. Courtet, and G. Vaiva, "Risk factors for treatment resistance in unipolar depression: a systematic review," Journal of affective disorders, Vol.171, pp.137-141, 2015.   DOI
62 A. A. Nierenberg, "Predictors of response to antidepressants: General principles and clinical implications," Psychiatric Clinics of North America, Vol.26, No.2, pp.345-352, 2003.   DOI
63 M. E. Thase, "Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies," Dialogues in clinical neuroscience, Vol.16, No.4, p.539, 2014.   DOI
64 F. Ali and C. B. Nemeroff, "Neuroendocrine Alterations in Major Depressive Disorder," in Major Depressive Disorder, Elsevier, pp.63-74, 2020.
65 M. R. Irwin and A. H. Miller, "Depressive disorders and immunity: 20 years of progress and discovery," Brain, behavior, and immunity, Vol.21, No.4, pp.374-383, 2007.   DOI
66 L. Bocchio-Chiavetto, V. Bagnardi, R. Zanardini, R. Molteni, M. Gabriela Nielsen, A. Placentino, and M. A. Riva, "Serum and plasma BDNF levels in major depression: a replication study and meta-analyses," The World Journal of Biological Psychiatry, Vol.11, No.6, pp.763-773, 2010.   DOI
67 J. P. Jacobsen, A. D. Krystal, K. R. Krishnan, and M. G. Caron, "Adjunctive 5-Hydroxytryptophan slow-release for treatment-resistant depression: clinical and preclinical rationale," Trends in pharmacological sciences, Vol.37, No.11, pp.933-944, 2016.   DOI
68 A. Dregan, L. Rayner, K. A. Davis, I. Bakolis, J. A. de la Torre, J. Das-Munshi, and M. Hotopf, "Associations between depression, arterial stiffness, and metabolic syndrome among adults in the UK Biobank Population Study: a mediation analysis," JAMA psychiatry, Vol.77, No.6, pp.598-606, 2020.   DOI
69 M. Fava, "Diagnosis and definition of treatment-resistant depression," Biological psychiatry, Vol.53, No.8, pp.649-659, 2003.   DOI
70 Y. G. Wei, D. B. Cai, R. X. Liu, J. Liu, S. B. Wang, Y. Q. Tang, and F. Wang, "Cholesterol and triglyceride levels in first-episode patients with major depressive disorder: A meta-analysis of case-control studies," Journal of Affective Disorders, Vol.266, pp.465-472, 2020.   DOI
71 S. Vivekanantham, R. Strawbridge, R. Rampuri, T. Ragunathan, and A. H. Young "Parity of publication for psychiatry," The British Journal of Psychiatry, Vol.209, No.3, pp.257-261, 2016.   DOI
72 S. Kapur, A. G. Phillips, and T. R. Insel, "Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?," Molecular psychiatry, Vol.17, No.12, pp.1174-1179, 2012.   DOI
73 A. Fekadu, L. J. Rane, S. C. Wooderson, K. Markopoulou, L. Poon, and A. J. Cleare, "Prediction of longer-term outcome of treatment-resistant depression in tertiary care," The British Journal of Psychiatry, Vol.201, No.5, pp.369-375, 2012.   DOI
74 A. Fekadu, S. C. Wooderson, K. Markopoulo, C. Donaldson, A. Papadopoulos, and A. J. Cleare, "What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies," Journal of affective disorders, Vol.116, No.1-2, pp.4-11, 2009.   DOI